These multiplied viral entry points might be the reason behind the high morbidity and mortality in COVID‐19 patients with hypertension or diabetes because patients having hypertension and/or diabetes take drugs targeting the renin‐angiotensin system (RAS) to lower blood pressure and protect kidney. Here, REN is linked to hypertensive disorder.